Drugmaker to Seek Approval for World’s First Malaria Vaccine

Your News Companion by Ben Mathis-Lilley
Oct. 8 2013 5:12 PM

Drugmaker to Seek Approval for World’s First Malaria Vaccine

86179461
South Sudanese children are educated on the use of a long-lasting insecticide-treated net.

Photo by TONY KARUMBA/AFP/Getty Images

British drug maker GlaxoSmithKline (GSK) is set to seek regulatory approval for the world’s first malaria vaccine after trials with the drug caused a 50 percent drop in the number of malaria cases in African children.

The vaccine is called RTS,S and was developed by GSK along with the non-profit Path Malaria Vaccine Initiative, with funding from the Bill and Melinda Gates Foundation. The vaccine has been in development by GSK for three decades and the trial was the largest-ever clinical trial conducted in Africa, involving almost 15,500 children across seven countries, the BBC reports.

Advertisement

The nearly 50 percent drop in childhood malaria cases, while dramatic, traditionally wouldn't make a vaccine a sure thing, as most childhood vaccines provide at least 90 percent protection, according to NBC News. The vaccine was also less effective in preventing malaria in infants with only 27 percent effectiveness. But, the sheer scope of the devastating impact of malaria, particularly in the developing world, makes grading on a curve more than acceptable, says GSK. “The sheer number of children affected by malaria means that the number of cases of the disease the vaccine can help prevent is impressive,” Andrew Witty, CEO of GSK, said in the statement. “These data support our decision to submit a regulatory application for the vaccine candidate.”

Malaria afflicts 216 million people each year and kills more than 600,000, where most of the fatalities are children under 5 years old in sub-Saharan Africa, according to the World Health Organization. According to Bloomberg, “GSK plans to submit the vaccine to the European Medicines Agency for approval next year, and the WHO has said it may in 2015 recommend RTS,S for use if safety and efficacy are satisfactory.”

GSK has pledged to keep the cost of the vaccine low, NPR reports, with prices no more than the cost of production plus a 5 percent profit that the company says it will invest in developing other vaccines for neglected diseases.

Elliot Hannon is a writer in Washington, D.C. Follow him on Twitter.

TODAY IN SLATE

Sports Nut

Grandmaster Clash

One of the most amazing feats in chess history just happened, and no one noticed.

The Extraordinary Amicus Brief That Attempts to Explain the Wu-Tang Clan to the Supreme Court Justices

Amazon Is Officially a Gadget Company. Here Are Its Six New Devices.

Uh-Oh. The World’s Oceans Have Broken Their All-Time Heat Record.

The NFL Explains How It Sees “the Role of the Female”

Future Tense

Amazon Is Now a Gadget Company

Food

How to Order Chinese Food

First, stop thinking of it as “Chinese food.”

The NFL Should Lose Its Tax-Exempt Status, Which It Never Should Have Had Anyway

The Country Where Women Aren’t Allowed to Work Once They’re 36 Weeks’ Pregnant

The XX Factor
Sept. 18 2014 11:40 AM The Country Where Women Aren’t Allowed to Work Once They’re 36 Weeks’ Pregnant
  News & Politics
Weigel
Sept. 18 2014 8:20 PM A Clever Attempt at Explaining Away a Vote Against the Farm Bill
  Business
Moneybox
Sept. 18 2014 6:02 PM A Chinese Company Just Announced the Biggest IPO in U.S. History
  Life
Outward
Sept. 18 2014 4:15 PM Reactions to a Sketch of Chelsea Manning Reveal Transmisogyny
  Double X
Doublex
Sept. 18 2014 8:07 PM Crying Rape False rape accusations exist, and they are a serious problem.
  Slate Plus
Behind the Scenes
Sept. 18 2014 1:23 PM “It’s Not Every Day That You Can Beat the World Champion” An exclusive interview with chess grandmaster Fabiano Caruana.
  Arts
Brow Beat
Sept. 18 2014 4:33 PM The Top 5 Dadsplaining Moments From The Cosby Show
  Technology
Future Tense
Sept. 18 2014 6:48 PM By 2100 the World's Population Could Be 11 Billion
  Health & Science
Bad Astronomy
Sept. 18 2014 7:30 AM Red and Green Ghosts Haunt the Stormy Night
  Sports
Sports Nut
Sept. 15 2014 9:05 PM Giving Up on Goodell How the NFL lost the trust of its most loyal reporters.